177 related articles for article (PubMed ID: 34900845)
1. A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol.
Styles S; Wheeler B; Boucsein A; Crocket H; de Lange M; Signal D; Wiltshire E; Cunningham V; Lala A; Cutfield W; de Bock M; Serlachius A; Jefferies C
J Diabetes Metab Disord; 2021 Dec; 20(2):2093-2101. PubMed ID: 34900845
[TBL] [Abstract][Full Text] [Related]
2. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
[No Abstract] [Full Text] [Related]
3. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
4. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes?
Elbalshy M; Boucher S; Galland B; Haszard JJ; Crocket H; Wiltshire E; Jefferies C; de Bock MI; Tomlinson P; Jones S; Wheeler BJ
J Diabetes Metab Disord; 2020 Dec; 19(2):1647-1658. PubMed ID: 33553041
[TBL] [Abstract][Full Text] [Related]
5. Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.
Wilmot EG; Evans M; Barnard-Kelly K; Burns M; Cranston I; Elliott RA; Gkountouras G; Kanumilli N; Krishan A; Kotonya C; Lumley S; Narendran P; Neupane S; Rayman G; Sutton C; Taxiarchi VP; Thabit H; Leelarathna L
BMJ Open; 2021 Jul; 11(7):e050713. PubMed ID: 34261691
[TBL] [Abstract][Full Text] [Related]
6. Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trial.
Sehgal S; De Bock M; Williman J; Taylor B; Elbalshy M; Galland B; Hall R; Paul R; Boucsein A; Jones S; Frewen C; Wheeler BJ
J Diabetes Metab Disord; 2021 Dec; 20(2):2103-2113. PubMed ID: 34900846
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal TP; Dørflinger L; Vistisen D; Nørgaard K
BMJ Open; 2020 Apr; 10(4):e036474. PubMed ID: 32345699
[TBL] [Abstract][Full Text] [Related]
8. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
[TBL] [Abstract][Full Text] [Related]
9. Protocol for a multi-site randomised controlled feasibility study investigating intermittently scanned blood continuous glucose monitoring use for gestational diabetes: the RECOGNISE study.
Davies A; Lenguerrand E; Scott E; Kandiyali R; Douek I; Norman J; Loose A; Sawyer L; Timlin L; Burden C
Pilot Feasibility Stud; 2023 Jul; 9(1):120. PubMed ID: 37434220
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
[TBL] [Abstract][Full Text] [Related]
11. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of unblinded and blinded intermittently scanned continuous glucose monitoring for glycemic control in adults with type 1 diabetes.
Guo L; Li Y; Zhang M; Xiao X; Kuang H; Yang T; Jia X; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1110845. PubMed ID: 36909344
[TBL] [Abstract][Full Text] [Related]
13. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
Brown RE; Chu L; Norman GJ; Abitbol A
Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
[TBL] [Abstract][Full Text] [Related]
14. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
[TBL] [Abstract][Full Text] [Related]
15. Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM study.
Lever CS; Williman JA; Boucsein A; Watson A; Sampson RS; Sergel-Stringer OT; Keesing C; Chepulis L; Wheeler BJ; de Bock MI; Paul RG
J Diabetes Metab Disord; 2023 Dec; 22(2):1779-1792. PubMed ID: 37969919
[TBL] [Abstract][Full Text] [Related]
16. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
17. The OPTIMISE study protocol: a multicentre optimisation trial comparing continuous glucose monitoring, snacking habits, sleep extension and values-guided self-care interventions to improve glucose time-in-range in young people (13-20 years) with type 1 diabetes.
Rose S; Haszard JJ; Galland BC; Wiltshire EJ; de Bock MI; Smart CE; Ketu-McKenzie M; Campbell A; Thomson R; Jefferies CA; Wheeler BJ; Styles SE
J Diabetes Metab Disord; 2022 Dec; 21(2):2023-2033. PubMed ID: 36404842
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
19. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
